Clinical requirements for locally applied, locally acting products containing known constituents

  • Email
  • Help
Current effective version

Adopted guideline

Currently under revision - see below

Reference numberCPMP/EWP/239/95
Published01/11/1995
Effective from01/06/1996
KeywordsTherapeutic equivalence, gastrointestinal, locally applied and locally acting, pharmacokinetic, bioequivalence
DescriptionThis document defines requirements for the clinical development of locally applied, locally acting products with known active substance. It provides guidance on the information to be included in the dossier.


Document history

Revision 1

In progress

Draft guideline

 

 

 

Concept paper

Published: 04/04/2017

 

Deadline for comments: 30/09/2017

 

Published: 01/10/2013

First version

Current version

Adopted guidelineIn operation: 01/06/1996–present


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more